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Background: Endovascular stent-graft placement for the treatment of patients with
aortic dissection is emerging as an attractive alternative to conventional cardiac
operations. However, there has been no report of longer-term follow-up. The
purpose of this study is to describe our midterm results with endovascular stent-graft
repair for the treatment of patients with aortic dissections.
Methods: Thirty-eight patients with aortic dissections with descending tears were
treated with endovascular stent-grafting. Ten patients had acute type A, 14 patients
had acute type B, and 14 patients had chronic type B dissection. Stent grafts
fabricated from expanded polytetrafluoroethylene-covered Z stents were placed to
close entry tears in all patients through the delivery systems introduced from the
femoral or the iliac arteries.
Results: Two patients with complicated acute type B dissection, who would have
required surgical intervention, died within 30 days of the procedure, although no
other patients died within the same period. There were no late deaths during the
mean follow-up period of 27 months. Early and late complication rates were 33%
and 36%, respectively, in patients with acute dissection, whereas rates were 4% and
0% (P  .05 vs patients with acute dissection) in patients with chronic dissection.
Conclusions: Entry closure with endovascular stent-graft placement may be a safe
and effective method for the treatment of patients with aortic dissection. It could be
an alternative to conventional surgical intervention in selected patients with chronic
dissection. However, strict patient selection and close follow-up seem mandatory in
patients with acute dissection receiving Z stent-based stent-grafts. Stent-graft repair
should be delayed for acute type B dissection without complications.
Aortic dissection is one of the most catastrophic events that affectsthe aorta. The overall in-hospital mortality rate for acute aorticdissection is greater than 20%, despite improved diagnostic andtherapeutic techniques.1 The treatment strategy depends on theextension of the dissecting process; that is, surgical repair isrequired when it involves the ascending aorta, and medical treat-
ment with the use of -blockers and vasodilators is preferred when it does not.2
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There are several challenging complexities in this strat-
egy. First, when aortic dissection is accompanied by com-
plications, including visceral ischemia, leg ischemia, and
aortic rupture, surgical intervention is required, even in
patients with type B dissections. The number of such pa-
tients reaches approximately 20%.1,3 However, the opera-
tive mortality and morbidity are extremely high in these
patients. Second, patients with uncomplicated type B aortic
dissections must undergo aggressive control of hypertension
during the first few weeks, and they have to be followed up
with strict medication for their lifetime.2,4,5 Even if patients
are compliant enough to obey all the medication require-
ments, there still remains concern about aortic rupture or
redissection. In addition, aneurysmal dilatation is observed
in more than 20% of these medically treated patients during
follow-up. Surgical repair of these patients is often exten-
sive and is associated with considerable mortality and mor-
bidity.6,7 Third, there are small subsets among type A dis-
section in which the entry tear locates in the descending
thoracic aorta and propagates up to the ascending aorta in a
retrograde manner. Extensive operation, including excision
of the entry tear, in addition to replacement of both the
ascending aorta and the aortic arch, is required for its
complete treatment.8,9
Entry closure with endovascular stent-graft placement
has emerged as a solution to these problems encountered in
the treatment of aortic dissection with a descending tear.10,11
The preliminary studies showed its effectiveness for the
treatment of both acute and chronic dissections. However,
both patient populations and follow-up term of those studies
are limited, and no longer-term follow-ups have been re-
ported. In addition, the timing of endovascular repair (ie,
when aortic dissections should be treated) is still controver-
sial in the acute or chronic phase. In this article we present
our experiences of the treatment of both acute and chronic
aortic dissections and their midterm results to clarify these
unanswered questions.
Patients and Methods
Patient Selection
We have treated 38 patients with aortic dissections since 1997
(Table 1). The study population consisted of 32 men and 6 women
with a mean age of 63  11 years (range, 38-82 years).
Inclusion criteria were as follows: (1) patients with type B
aortic dissection who have such complications as required surgical
intervention, including visceral or leg ischemia, aortic rupture,
refractory hypertension, and refractory pain; (2) patients with type
A aortic dissection with the entry tear in the descending thoracic
aorta; (3) patients with type B dissection with a descending tho-
racic aorta of 40 mm or larger in diameter at the onset of aortic
dissection; (4) patients with a descending thoracic aorta 50 mm or
larger in diameter at any time; and (5) patients with growing
ulcer-like projections.
The exclusion criteria were as follows: (1) distance between the
entry tear and the left subclavian artery of less than 5 mm; (2)
diameter of the access artery (ie, the femoral and iliac artery) of
less than 7 mm; and (3) existence of complications requiring an
emergency operation, including cardiac tamponade, ischemia of
the coronary artery or cervical branches, and aortic regurgitation.
Both inclusion criteria and exclusion criteria were applied to
patients with both acute and chronic dissections.
The institutional review board approved this study, and full
informed consent was obtained from each patient.
Preprocedural Imaging
Computed tomography (CT) and calibrated angiography were per-
formed preoperatively in all patients. In patients with chronic
dissections, the diameters of the stent grafts were determined to be
approximately 10% to 20% larger than that of the aorta proximal
to the entry tear, as measured on contrast-enhanced CT. In patients
with acute dissections, the approximately same diameter as that of
the aorta proximal to the entry tear was adopted as the diameter of
the stent graft.
The distance between the entry tear and the left subclavian
artery was measured on a calibrated angiographic scan in most
cases. Three-dimensional reconstruction or multiplanar reconstruc-
tion images elaborated from axial CT images were used in some
cases to measure the distance and the shape of the entry tear.
TABLE 1. Comparison of dissection-related complications between patients with acute and chronic dissections
Type A
Type B
(complicated)
Acute type B
(uncomplicated) Total (type B) Total (acute)
Chronic
type B
n 10 6 8 14 24 14
Age (y) 60 9 69 5 64 7 66 6 63 8 61 14
Male sex 100% (10/10) 67% (4/6) 75% (6/8) 71% (10/14) 83% (20/24) 86% (12/14)
Interval between diagnosis and stent grafting 8 7 d* 4 8 d* 12 8 d* 9 9 d* 8 8 d* 35 94 mo
Dissection-related complications 8 (80%)* 6 (100%)* 0 (0%) 6 (43%)* 14 (58%)* 0 (0%)
Aortic rupture 1 (10%) 2 (33%)† 0 (0%) 2 (14%) 3 (13%) 0 (0%)
Refractory pain/hypertension 3 (30%)† 2 (33%)† 0 (0%) 2 (14%) 5 (21%) 0 (0%)
Visceral/renal/leg ischemia 0 (0%) 2 (33%)† 0 (0%) 2 (14%) 2 (8%) 0 (0%)
Pericardial effusion 5 (50%) 0 (0%) 0 (0%) 0 (0%) 5 (21%) 0 (0%)
Aortic regurgitation 1 (10%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%)
Paraparesis 1 (10%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%)
*P  .01 versus chronic dissection.
†P  .05 versus chronic dissection.
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The length of the stent-graft was 7.5 cm in most cases, in which
the entry tear was like a pinhole. However, in some cases the
length of the stent graft was 10 cm or longer because the entry
tears had considerable longitudinal length.
Device Details
We used custom-made stent-grafts in all patients. Stent-grafts were
fabricated from Z stents (Cook, Bloomington, Ind) covered with
expanded polytetrafluoroethylene (Impra, Tempe, Ariz), which
was dilated with balloon catheters until the expected diameter was
obtained, or from Z stents covered with woven polyester (Ube,
Yamaguchi, Japan). Graft materials were attached to Z stents with
polypropylene sutures (Ethicon, Inc, Somerville, NJ). An 18F or
20F delivery system (Cook) was used for deployment.
Methods
The methods are almost the same as those described in previous
reports.10 Stent-graft placement was performed after achievement
of general anesthesia in all patients. After femoral or external iliac
arteriotomy, the delivery system was advanced until its tip reached
proximal to the entry tear. Then stent-grafts were inserted and
advanced into the delivery system. Stent-grafts were deployed
through a quick drawback of the outer sheath during firm holding
of the pusher mandrel. Blood pressure control with a vasodilator or
transient cardiac arrest with adenosine was adopted in all patients
to avoid misplacement. Whenever any endoleak was noticed on
angiography, additional procedures, including balloon dilatation
and additional stent-grafting, were added.
Statistical Analysis
Patient characteristics and mortality and morbidity rates with acute
and chronic dissection were compared by the 2 and Student t
tests. Actuarial survivals, complication-free rates, and reinterven-
tion-free rates of acute and chronic dissections were compared
with the log-rank test.
Results
Patient Demographics
Twenty-four (63%) patients underwent stent-graft repair
within 1 month of the diagnosis (acute, Table 1). The
interval between the diagnosis and stent grafting ranged
from 0 to 27 days (mean, 8  8 days) in this group. Ten
patients had Stanford type A acute dissection, and 14 pa-
tients had type B acute dissection. Among 14 patients with
type B dissection, 6 patients had complications requiring
surgical repair, and the other 8 patients did not. The other 14
(37%) of the 38 patients underwent stent-graft repair 1
month or later after the diagnosis (chronic). The interval
between the diagnosis and stent grafting ranged from 1
month to 30 years (mean, 35  94 months) in this group.
All patients of this group had type B chronic dissections.
The dissection-related complication rate of patients with
acute dissection was significantly higher than that of pa-
tients with chronic dissection (Table 1). There was no
significant difference in the dissection-unrelated complica-
tion rate, except for history of ascending aortic replacement
(Table 2).
Immediate Outcomes
Immediate outcome data are shown in Table 3.
Mortality. Two patients with complicated acute type B
dissection died within 30 days of the procedure, and no
other patients died within the same period. Specifically, one
third of patients with complicated acute type B dissections
died within 1 month (P  .05 vs patients with chronic
dissection). One patient had visceral ischemia before stent-
graft repair. Although entry closure was successful, he died
of bowel infarction on the next day. The other patient had
massive hematoma in the pleural space caused by aortic
rupture. He died of pneumonia on the ninth postoperative
day, despite complete closure of the entry tear and throm-
bectomy with thoracoscopy.
Morbidity. Intraoperative complications, including inti-
mal injury caused by balloon dilatation and minor stroke,
were observed in 2 patients with acute dissection, although
they were not observed in patients with chronic dissection.
TABLE 2. Comparison of preoperative risk factors between patients with acute and chronic dissections
Type A
Type B
(complicated)
Acute type B
(uncomplicated) Total (type B) Total (acute)
Chronic
type B
n 10 6 8 14 24 14
Dissection-unrelated complications 8 (80%) 5 (83%) 8 (100%) 13 (93%) 21 (88%) 12 (86%)
Hypertension 7 (70%) 4 (67%) 7 (88%) 11 (79%) 18 (75%) 9 (64%)
History of ascending aortic replacement N/A 0 (0%) 0 (0%) 0 (0%) 0 (0%)* 3 (21%)
AAA/TAA 1 (10%) 0 (0%) 3 (38%) 3 (21%) 4 (17%) 1 (7%)
Aortic regurgitation 0 (0%) 1 (17%) 1 (13%) 2 (14%) 2 (8%) 0 (0%)
Coronary arterial disease 1 (10%) 0 (0%) 1 (13%) 1 (7%) 2 (8%) 1 (7%)
Renal failure 1 (10%) 1 (17%) 0 (0%) 1 (7%) 2 (8%) 0 (0%)
Stroke 1 (10%) 0 (0%) 0 (0%) 0 (0%) 0 (10%) 0 (0%)
Coagulopathy 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (7%)
AAA, Abdominal aortic aneurysm; TAA, thoracic aortic aneurysm.
*P  .05 versus chronic dissection.
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Postoperative complications, including both aorta-related
and aorta-unrelated complications, were observed in 8
(33%) patients with acute dissection. In contrast, it was
observed only in 1 (4%) patient with chronic dissection.
Aorta-related complications, including endoleak and aneu-
rysmal degeneration of the aorta, were observed in as many
as 6 (25%) patients with acute dissection, although such
complications were not observed in any patient with chronic
dissection (0%). Endoleak was observed in 2 patients. It was
repaired with additional stent-grafting in 1 patient and with
graft replacement in the other patient. Aneurysms newly
developing at the aorta, the false lumen of which was once
completely thrombosed after stent-grafting, were referred to
as aneurysmal degeneration. This was observed at 6 sites in
5 patients during the whole follow-up period and was re-
paired with additional stent-grafting in 3 patients and with
graft replacement in 1 patient; it had been observed until
acute type A dissection developed in 1 patient.
The postoperative complication rate of patients with
complicated acute type B dissections was significantly
higher than that of patients with chronic dissections (P 
.05).
Late Outcomes
Late outcome data are shown in Table 4.
Mortality. There were no late deaths during the mean
follow-up period of 27  12 months (range, 6-53 months).
TABLE 3. Comparison of early mortality and morbidity between patients with acute and chronic dissections
Type A
Type B
(complicated)
Acute type B
(uncomplicated) Total (type B) Total (acute)
Chronic
type B
n 10 6 8 14 24 14
Mortality 0 (0%) 2 (33%)* 0 (0%) 2 (14%) 2 (8%) 0 (0%)
Complication 3 (30%) 3 (50%)* 2 (25%) 5 (36%) 8 (33%) 1 (7%)
Intraoperative 1 (10%) 1 (17%) 0 (0%) 1 (7%) 2 (8%) 0 (0%)
Intimal injury 1 (10%) 1 (17%) 0 (0%) 1 (7%) 2 (8%) 0 (0%)
Stroke 1 (10%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%)
Postoperative 3 (30%) 3 (50%)* 2 (25%) 5 (36%) 8 (33%) 1 (7%)
Aorta-related complication 2 (20%) 2 (33%)* 2 (25%) 4 (29%) 6 (25%) 0 (0%)
Endoleak 1 (10%) 0 (0%) 1 (13%) 1 (7%) 2 (8%) 0 (0%)
Aneurysmal degeneration 1 (10%) 1 (17%) 0 (0%) 1 (7%) 2 (8%) 0 (0%)
Rupture of AAA 0 (0%) 0 (0%) 1 (13%) 1 (7%) 1 (4%) 0 (0%)
Bowel infarction 0 (0%) 1 (17%) 0 (0%) 1 (7%) 1 (4%) 0 (0%)
Aorta-unrelated complication 1 (10%) 1 (17%) 0 (0%) 1 (7%) 2 (8%) 1 (7%)
Respiratory failure 1 (10%) 1 (17%) 0 (0%) 1 (7%) 2 (8%) 0 (0%)
Left arm ischemia 1 (10%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%)
Wound infection 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (7%)
AAA, Abdominal aortic aneurysm.
*P  .05 versus chronic dissection.
TABLE 4. Comparison of late mortality and morbidity between patients with acute and chronic dissections
Type A
Type B
(complicated)
Acute type B
(uncomplicated) Total (type B) Total (acute)
Chronic
type B
n 10 4 8 12 22 14
Mortality 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Complication 2 (20%) 2 (50%)* 4 (50%)* 6 (50%)* 8 (36%)† 0 (0%)
Aorta-related complication 1 (10%) 2 (50%)* 3 (38%)† 5 (42%)* 6 (27%) 0 (0%)
Aneurysmal degeneration 0 (0%) 2 (50%)* 2 (25%)† 4 (33%)† 4 (18%) 0 (0%)
Growth of another ULP 0 (0%) 0 (0%) 1 (13%) 1 (8%) 1 (5%)† 0 (0%)
Growth of AAA 1 (10%) 0 (0%) 0 (0%) 0 (0%) 1 (5%)† 0 (0%)
Acute type A dissection 0 (0%) 0 (0%) 1 (13%) 1 (8%) 1 (5%)† 0 (0%)
Aorta-unrelated complication 1 (10%) 0 (0%) 1 (13%) 1 (8%) 2 (9%)† 0 (0%)
Myocardial infarction 1 (10%) 0 (0%) 0 (0%) 0 (0%) 1 (5%)† 0 (0%)
Paraplegia 0 (0%) 0 (0%) 1 (13%) 1 (8%) 1 (5%)† 0 (0%)
ULP, Ulcer-like projection; AAA, abdominal aortic aneurysm.
*P  .01 versus chronic dissection.
†P  .05 versus chronic dissection.
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One-year survival of patients with acute and chronic dis-
sections was 92% and 100%, respectively.
Morbidity. Morbidity results are shown in Figures 1 and
2. Late complications were observed in as many as 8 (36%)
patients with acute dissection, whereas there were no late
complications in patients with chronic dissections (P 
.05). Specifically, aneurysmal degeneration was observed in
4 patients with acute dissections. It developed at the prox-
imal descending thoracic aorta proximal to the stent-grafts
in all patients. The interval between the diagnosis and
notification of the aneurysmal degeneration ranged from 17
to 99 days (mean, 63  29 days). The 1-year, aorta-related,
complication-free rates of patients with acute and chronic
dissection were 56% and 100%, respectively. The 1-year
reintervention-free rates were 60% and 100%, respectively.
Acute myocardial infarction developed in 1 patient with
acute dissection at 1 year after the stent-graft repair, which
was deemed not related to aortic dissection or the stent graft.
Paraplegia developed after surgical conversion performed 4
months after stent-graft placement to fix an endoleak in 1
patient with acute type B dissection.
Procedural Success
Primary success was defined as patients who are alive
during the follow-up period, with complete closure of the
entry tears and no aorta-related complications requiring
secondary intervention. Secondary success was defined as
patients who are alive during the follow-up period with
complete closure of the entry tears and no aorta-related
complications after primary or secondary intervention. The
primary success rate of patients with chronic dissection was
significantly higher than that of patients with acute dissec-
tion (Table 5). However, there was no significant difference
with the secondary success rate, except for that of patients
with complicated acute type B dissections.
Discussion
Stent-Graft Repair of Chronic Aortic Dissection
Nienaber and colleagues compared stent-graft repair with
surgical graft replacement for the treatment of chronic aortic
dissection.11 In their series no deaths or major complications
were observed in the group undergoing stent-graft repair,
whereas there were 4 deaths and 5 serious adverse events in
the surgical repair group. Although the number of the pa-
tients was extremely limited, there was a significant differ-
ence in operative mortality and morbidity between groups
undergoing stent-graft repair and surgical repair.
There have been several similar reports in which chronic
aortic dissection was treated with endovascular stent graft-
ing, and its safety and effectiveness were proved.12,13 This is
not surprising because stent-graft repair is far less invasive
than surgical repair, which often requires extensive resec-
tion of the descending thoracic aorta and is associated with
severe morbidities, including respiratory failure, renal fail-
ure, and spinal ischemia. This also matches our results with
chronic dissection.
We divided patients into the 2 groups described above
(ie, acute and chronic dissection) because the period of 1
month is clinically a turning point. In other words, both the
adventitia and dissected flap, which are extremely fragile in
the acute phase, seemingly become stable after this critical
period. Indeed, there were no deaths or major complica-
tions, including aorta-related complications, in patients with
chronic dissections in our series. This fact seemingly cor-
relates with the characteristics of the aortic wall in the
chronic phase (ie, stable and fibrotic adventitia and intimal
flap that can well tolerate the hoop strength of the stent-
grafts and other hemodynamic effects leading to aorta-
related complications).
Stent-Graft Repair of Acute Aortic Dissection
Dake and associates11 and we were the first to apply endo-
vascular stent-graft placement for the treatment of acute
Figure 1. Actuarial aorta-related complication-free rate.
Figure 2. Actuarial reintervention-free rate curve.
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aortic dissection in clinical settings. Dake and associates
accumulated a lot of data about the treatment of aortic
dissection through experimental and clinical practice and
concluded that entry closure with stent-grafts is the simplest
and most effective method, especially for the treatment of
true luminal compression.14-17 They treated 19 patients with
acute dissection, among whom 13 patients had severe com-
plications. The mortality rate was 21% in their series, which
may be acceptable when taking into consideration that more
than half of the patients had severe complications. In addi-
tion, there were no complications, including aortic aneu-
rysm or aortic rupture, during follow-up in their series.
In contrast, we experienced variable adverse events, in-
cluding aorta-related events. Intimal injury during the stent-
graft procedure must be caused by the edge of the stent-
grafts. Although the cause of aneurysmal degeneration after
stent-graft repair is not well known and some of them may
be phenomena observed during the natural course of the
dissected aorta, the edges of the stent-graft were thought to
be the trigger of aneurysm development in at least 2 cases in
our series. These complications are likely enough in patients
with acute dissection because the aortic wall is extremely
fragile and is easily injured by any stimulus, including the
edges of stent-grafts and endovascular procedures them-
selves. Although there is no clear evidence to explain the
difference between the results of the series by Dake and
associates10 and those of our series, the tendency to use
stent-grafts with larger diameters in our series may have
affected the results.
Avoidance of Intraoperative and Postoperative
Complications
Several methods may be used to avoid these complications.
First, stent-grafts should be placed to cover longer portions
of the descending aorta. Aneurysmal degeneration devel-
oped at the proximal portion of the descending aorta to the
stent-grafts in 4 of 5 patients in our series. Therefore,
covering the longer portion of the descending aorta, span-
ning from the origin of the descending aorta to the lower
portion to the entry tear, may potentially avoid this compli-
cation.
In 1 patient of our series, the stent-graft was placed in the
curved portion of the descending aorta, and the bottom edge
of the stent-graft was attached to the intimal flap at an angle.
Subsequently, aneurysmal degeneration developed at the
bottom end of the stent-graft in this patient. Because the
angle made by the bottom edge of the stent-graft and the
aortic wall seems to be the contributing factor of aneurys-
mal degeneration, several stent-grafts should be placed until
the surface of the bottom stent of the stent-graft locates
parallel to the aortic wall.
Second, more sophisticated stent-grafts, which have far
smoother edges and far more flexible bodies than those of Z
stent–based stent-grafts, should be used. If such stent-grafts
are available, the risk of flap injury caused by the edges of
stent-grafts may potentially be avoided, and stent-grafts
may be placed without any concern, even in the curved
portion of the aorta.
Indication for Stent-Graft Repair of Acute Dissection
The indications for endovascular stent-graft repair for the
treatment of acute dissection may have to undergo some
changes. Stent-grafting for the treatment of patients with
complicated type B dissections with complications, includ-
ing visceral ischemia, leg ischemia, or aortic rupture, or
patients with type A dissection with the entry tear in the
descending thoracic aorta may be justified, taking into con-
sideration that operative mortality and morbidity are ex-
tremely high in these patients.1,10,18
However, it should be better to delay the stent-graft
repair until the fragile aortic wall, including the intimal flap,
becomes more fibrotic and stable, if possible. Because our
data show that no deaths or aorta-related complications
were observed in patients with chronic dissections, it should
be obvious that delayed treatment may result in greater
benefit when Z stent-based stent-grafts are used. Patients
with acute type B dissections with descending thoracic
aortas of 40 mm in diameter or larger at the onset of aortic
dissection were enrolled in the present series because aneu-
rysmal dilatation is often observed during follow-up in such
patients.19 However, stent-graft repair should be delayed for
these patients when no dissection-related complication is
associated.
The recent advanced and sophisticated medical control
has reduced the mortality rate of the patients with type B
aortic dissection to approximately 10%.1 This figure is
TABLE 5. Comparison of procedural success rates between patients with acute and chronic dissections
Type A
Type B
(complicated)
Acute type B
(uncomplicated) Total (type B) Total (acute)
Chronic
type B
n 10 6 8 14 24 14
Primary success 7 (70%)† 2 (33%)* 5 (63%)† 7 (50%)* 14 (58%)* 14 (100%)
Secondary success 10 (100%) 4 (67%)† 8 (100%) 12 (86%) 22 (92%) 14 (100%)
*P  .01 versus chronic dissection.
†P  .05 versus chronic dissection.
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comparable with our results of patients with acute dissec-
tion. The relationship between medical control and stent-
graft repair seems like that between medical control and
surgical intervention in the 1970s and 1980s, when there
was controversy as to the appropriate treatment of acute
type B dissection.4-6,20 When stent-graft repair with a more
sophisticated device works well and without any significant
complications, there should be great benefit compared with
that seen with medical control, even in patients without any
dissection-related complication because patients need not
have concern about late complications, including aortic
rupture, redissection, or late surgical repair because of an-
eurysmal dilatation of the dissected aorta.
Conclusion
From our small experience, stent-graft repair of type B
aortic dissection 1 month after the diagnosis may be a safe
and effective method and an alternative to surgical repair in
selected patients. In addition, patients with complicated
acute type B dissections and those with type A dissections
may benefit from this procedure. However, it should be
better that stent-graft repair be delayed until the aortic wall
becomes fibrotic and stable in patients with uncomplicated
acute type B dissections when the so-called first-generation
stent-grafts are used.
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